News Coverage 12.06.20 Share on Twitter Share on Facebook Share on LinkedIn Biomarker predicts poor response to CAR-T, points way to personalized, gene-edited therapy Related Announcement, Our Impact PICI-Founded Dispatch Bio Takes on Solid Tumors Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker Research Update Data to Design: Inside Our Spring Scientific Retreat